Rebate Game Played By PBMs And Drug Makers Limits Biosimilar Competition
The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.
Access to naloxone still challenging in Australia, with stigma and knowledge gaps within pharmacy sector creating barriers
Since 2022, the federal government has invested $26.1 million to help make naloxone, a medicine that blocks the effects of ...
Harrow: VEVYE And Its Impact On The DED Market
Harrow Inc. experienced a brief 20% stock drop in October but quickly recovered, showing resilience despite recent revenue channel underperformance. Read more here.
CNET on MSN15h
Which Decongestants Are Effective? Why the FDA Wants to Pull a Popular Medicine Ingredient
Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 8, 2024 Xeris Biopharma Holdings, Inc. beats earnings expectations. Reported EPS is ...
Veterans targeted by medicinal cannabis businesses on social media spruiking free products and subscriptions
Veterans are being targeted by social media ads offering access to "free" medicinal cannabis, funded by the Department of ...
Apple Intelligence should make phone calls on the iPhone a better experience — and the Google Pixel shows how
When it comes to future Apple Intelligence features for the iPhone, I hope Apple doesn't forget about the phone.
The Jerusalem Post Blogs5h
From the Valley to Divine Connection: The Journal Sparking Spiritual Revolution in Israel
Carolina Lemke Berlin, the beloved and leading eyewear brand in Israel, is currently launching its new collection of ...